• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Total paracentesis with dextran 40 vs diuretics in the treatment of ascites in cirrhosis: a randomized controlled study.

作者信息

Solà R, Vila M C, Andreu M, Oliver M I, Coll S, Gana J, Ledesma S, Ginès P, Jiménez W, Arroyo V

机构信息

Gastroenterology Unit, Hospital del Mar, Universitat Autònoma de Barcelona, Spain.

出版信息

J Hepatol. 1994 Feb;20(2):282-8. doi: 10.1016/s0168-8278(05)80070-4.

DOI:10.1016/s0168-8278(05)80070-4
PMID:7516361
Abstract

The aim of the current study was to compare total paracentesis associated with dextran-40 infusion with diuretics in the treatment of tense ascites in patients with cirrhosis. Eighty patients were randomly allocated to two groups: 40 patients were treated with paracentesis plus dextran-40 infusion (8 g per liter of ascitic fluid removed), and 40 patients with diuretics. After treatment patients were discharged with diuretics, and patients developing tense ascites during follow up (54 +/- 4 weeks) were treated according to their initial schedule. Paracentesis was more effective than diuretics in mobilizing the ascitic fluid. The incidence of complications was significantly higher (p < 0.05) in the diuretic group (38%) than in the paracentesis group (15%). This difference was mainly due to a higher incidence of hepatic encephalopathy in the former group (30% vs. 2.5%). A significantly higher incidence of hepatic encephalopathy was also observed in the diuretic group during the follow-up readmissions for ascites recurrence. There were no significant differences between the two treatment groups in the probability of survival after inclusion. Plasma renin activity and plasma aldosterone concentration measured before and 2 and 6 days after paracentesis in 20 randomly selected patients increased significantly (p < 0.05) (baseline values: 5.3 +/- 1.4 ng.ml-1.h-1 and 63 +/- 21 ng/dl; 48 h after paracentesis: 11.7 +/- 3.9 ng.ml-1.h-1 and 99 +/- 31 ng/dl; 6 days after paracentesis: 10.9 +/- 3 ng.ml-1.h-1 and 110 +/- 27 ng/dl).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

相似文献

1
Total paracentesis with dextran 40 vs diuretics in the treatment of ascites in cirrhosis: a randomized controlled study.
J Hepatol. 1994 Feb;20(2):282-8. doi: 10.1016/s0168-8278(05)80070-4.
2
Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study.右旋糖酐70与白蛋白作为肝硬化大量腹水患者经完全腹腔穿刺放液治疗时的血浆扩容剂。一项随机研究的结果
Gastroenterology. 1990 Dec;99(6):1736-44. doi: 10.1016/0016-5085(90)90481-f.
3
Diuretic requirements after therapeutic paracentesis in non-azotemic patients with cirrhosis. A randomized double-blind trial of spironolactone versus placebo.非氮质血症肝硬化患者治疗性腹腔穿刺放液后的利尿剂需求。螺内酯与安慰剂的随机双盲试验。
J Hepatol. 1997 Mar;26(3):614-20. doi: 10.1016/s0168-8278(97)80427-8.
4
Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study.腹腔穿刺术与利尿剂治疗肝硬化腹水患者的比较:一项随机研究的结果
Gastroenterology. 1987 Aug;93(2):234-41. doi: 10.1016/0016-5085(87)91007-9.
5
Paracentesis with Dextran 70 vs. paracentesis with albumin in cirrhosis with tense ascites. Results of a randomized study.右旋糖酐70腹腔穿刺术与白蛋白腹腔穿刺术治疗肝硬化伴大量腹水的随机研究结果
J Hepatol. 1992 Mar;14(2-3):310-6. doi: 10.1016/0168-8278(92)90176-p.
6
Atrial natriuretic factor in cirrhotic patients with tense ascites. Effect of large-volume paracentesis.肝硬化伴张力性腹水患者的心房利钠因子。大量腹腔穿刺放液的影响。
Gastroenterology. 1990 Apr;98(4):1063-70. doi: 10.1016/0016-5085(90)90034-x.
7
Spontaneous bacterial peritonitis in cirrhotic patients treated using paracentesis or diuretics: results of a randomized study.
Hepatology. 1995 Feb;21(2):340-4. doi: 10.1002/hep.1840210212.
8
Diuretics vs. paracentesis followed by diuretics in cirrhosis: effect on ascites opsonic activity and immunoglobulin and complement concentrations.肝硬化患者使用利尿剂与腹腔穿刺放液后再用利尿剂的比较:对腹水调理素活性及免疫球蛋白和补体浓度的影响
Hepatology. 1994 Feb;19(2):346-53. doi: 10.1002/hep.1840190212.
9
Clinical and neurohumoral response to posture, physical exercise, and ascites treatment in Child-Pugh C liver cirrhosis: randomized prospective trial.Child-Pugh C级肝硬化患者对体位、体育锻炼及腹水治疗的临床和神经体液反应:随机前瞻性试验
Croat Med J. 2003 Apr;44(2):178-86.
10
Treatment of cirrhotic tense ascites with Dextran-40 versus albumin associated with large volume paracentesis: a randomized controlled trial.右旋糖酐40与白蛋白联合大量腹腔穿刺术治疗肝硬化张力性腹水:一项随机对照试验
Ann Hepatol. 2002 Jan-Mar;1(1):29-35.

引用本文的文献

1
Use of albumin infusion for cirrhosis-related complications: An international position statement.白蛋白输注在肝硬化相关并发症中的应用:一项国际立场声明。
JHEP Rep. 2023 May 5;5(8):100785. doi: 10.1016/j.jhepr.2023.100785. eCollection 2023 Aug.
2
Indian College of Radiology and Imaging Evidence-Based Guidelines for Interventions in Portal Hypertension and Its Complications.印度放射学与影像学学院门静脉高压及其并发症干预的循证指南
Indian J Radiol Imaging. 2022 Jan 10;31(4):917-932. doi: 10.1055/s-0041-1740235. eCollection 2021 Oct.
3
Long-term administration of Tolvaptan to patients with decompensated cirrhosis.
托伐普坦治疗失代偿期肝硬化患者的长期疗效。
Int J Med Sci. 2020 Mar 15;17(7):874-880. doi: 10.7150/ijms.41454. eCollection 2020.
4
Treatment for ascites in adults with decompensated liver cirrhosis: a network meta-analysis.失代偿期肝硬化成人腹水的治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 16;1(1):CD013123. doi: 10.1002/14651858.CD013123.pub2.
5
Clinical Profile and Complications of Paracentesis in Refractory Ascites Patients With Cirrhosis.肝硬化难治性腹水患者腹腔穿刺术的临床特征及并发症
Gastroenterology Res. 2015 Aug;8(3-4):228-233. doi: 10.14740/gr661w. Epub 2015 Jul 22.
6
Cross-Sectional Guidelines for Therapy with Blood Components and Plasma Derivatives: Chapter 5 Human Albumin - Revised.血液成分及血浆衍生物治疗的横断面指南:第5章 人血白蛋白 - 修订版
Transfus Med Hemother. 2016 May;43(3):223-32. doi: 10.1159/000446043. Epub 2016 May 3.
7
Evidence-based clinical practice guidelines for liver cirrhosis 2015.2015 年肝硬化循证临床实践指南。
J Gastroenterol. 2016 Jul;51(7):629-50. doi: 10.1007/s00535-016-1216-y. Epub 2016 May 31.
8
AISF-SIMTI position paper: the appropriate use of albumin in patients with liver cirrhosis.AISF-SIMTI立场文件:肝硬化患者白蛋白的合理使用
Blood Transfus. 2016 Jan;14(1):8-22. doi: 10.2450/2016.0294-15.
9
Management of cirrhotic ascites.肝硬化腹水的管理
Ther Adv Chronic Dis. 2015 May;6(3):124-37. doi: 10.1177/2040622315580069.
10
Diagnosis and therapy of ascites in liver cirrhosis.肝硬化腹水的诊断与治疗。
World J Gastroenterol. 2011 Mar 14;17(10):1237-48. doi: 10.3748/wjg.v17.i10.1237.